PALO ALTO, Calif. & MCLEAN, Va.--(BUSINESS WIRE)--Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!

Strategic partnership will link DNA data with rich clinical data to identify novel biomarkers for targeted cancer therapies The two companies will utilize AI and multimodal molecular data to unlock ...

Strategic partnership will link DNA data with rich clinical data to identify novel biomarkers for targeted cancer therapies The two companies will utilize AI and multimodal molecular data to unlock ...

For the quarter ended September 2025, Guardant Health (GH) reported revenue of $265.2 million, up 38.5% over the same period last year. EPS came in at -$0.39, compared to -$0.45 in the year-ago ...